SB-485232: Clinical Trials

1 trial of SB-485232, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow SB-485232: new trials by email Literature Review of SB-485232 trials Research Report on SB-485232

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Anti-Tumor Activity Of SB-485232 In Patients With Previously Untreated Metastatic Melanoma
SB-485232 - Melanoma
Phase 2CompletedGlaxoSmithKline642004-11-152017-07-27

Conditions studied

Melanoma (1)

Sponsors

GlaxoSmithKline (1)

Countries

Australia (1)  ·  United States (1)